Aurobindo Pharma has issued and allotted $60 million Foreign Currency Convertible Bonds (FCCBs), due 2010, and the bonds have been listed on Singapore Exchange Securities Trading.According to a release issued by Aurobindo Pharma to the BSE, the FCCBs are convertible into equity shares within a period of five years at a conversion price of Rs 522.036 per share. Barclays Bank PLC has acted as the sole lead manager and book runner to this FCCB issue.
